You searched for " retina"
Transforming eyecare with AI at 100% Optical
4 March 2024
|
Pearse Keane, AI, Moorfields, UCL, technology, advancement, artificial intelligence, development
“We are drowning in people we need to see in hospital eye services, and some people are going blind as a result. We are looking at nearly 10m hospital appointments for ophthalmology a year, with an approximately 33% increase over...
ARN in North Africa
1 December 2015
| Saruban Pasu
|
EYE - Vitreo-Retinal
Acute retinal necrosis (ARN) is a rare cause of uveitis. This paper aims to outline the clinical features of 12 patients with ARN in a referral centre in Tunisia, North Africa. A retrospective review of case notes was carried out....
The reps
1 August 2019
| Gwyn Samuel Williams
|
EYE - General
Who are the reps? Every one of us knows the friendly face of the local randomprost eye drop representative or the nice man from that eye lubricant company. These company representatives travel up and down the region with a smile,...
RPE tears after intravitreal Lucentis
1 February 2017
| Saruban Pasu
|
EYE - Vitreo-Retinal
The current hypothesis regarding retinal pigment epithelium (RPE) tears is the contraction and fibrosis in choroidal neovascularisation (CNV) tissue after anti-VEGF therapy can induce rips in the overlying RPE. This South Korean study aimed to identify the association between RPE...
Ginko bilboa extract affects hypoxic retinal pigment epithelial cells
1 February 2014
| Khadijah Basheer
|
EYE - Vitreo-Retinal
Wet age-related macular degeneration (AMD) is characterised by choroidal neovascular membrane (CNVM) formation. It is thought that localised hypoxia within the retina results in overexpression of growth factors such as vascular endothelial growth factor (VEGF), which induces CNVM formation. VEGF...
OCTA in diabetic macular oedema treated with intravitreal aflibercept (DOCTA Study)
3 April 2024
| Sofia Rokerya
|
EYE - Vitreo-Retinal
Central vision loss due to diabetic macular oedema (DME) can be attributed not only to presence of the macular oedema itself but also, in some cases, to alterations of the foveal avascular zone (FAZ). The DOCTA trial was a longitudinal,...
The University of Auckland, New Zealand - Ophthalmology Sub-speciality Fellowship Applications Open – Deadline 18 June 2021
9 April 2021
The Department of Ophthalmology at the University of Auckland and Greenlane Hospital, Auckland District Health Board have openings.
Short-term effects of intravitreal bevacizumab on the cornea
1 December 2014
| Khadijah Basheer
|
EYE - Cornea, EYE - General
|
anterior chamber depth, bevacizumab, central corneal thickness, intraocular pressure, iridocorneal angle, simulated keratometry
Bevacizumab has been extensively used to treat macula oedema and neovascularisation of the retina and it has also been useful in the management of corneal neovascular diseases. This prospective study aimed to provide more information on the effect bevacizumab may...
Variability and reliability of Lea grating paddles
The authors aimed to determine interobserver variability and reliability of Lea grating paddles when assessing grating acuity in pre and non-verbal children. This was a prospective study of 31 consecutive patients; 29 pre-verbal <36 months and two with delayed speech...RSM (The Royal Society of Medicine): Update on retinal disorders
18 May 2023
Join this virtual meeting to gain an update from experts in the field, this webinar will provide general ophthalmologists as well as those with interest in retinal disorders with an informative update on retinal disease. The aim of this meeting...
